PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19411632-4	2009	Treatment of ITD-Flt3(+) human MV4-11 leukemia cells with the ITD-Flt3 inhibitor SU5416 reduced Survivin expression and inhibited cell proliferation.	Semaxinib	81-87	fms related receptor tyrosine kinase 3	Homo sapiens	17-21	
19411632-4	2009	Treatment of ITD-Flt3(+) human MV4-11 leukemia cells with the ITD-Flt3 inhibitor SU5416 reduced Survivin expression and inhibited cell proliferation.	Semaxinib	81-87	fms related receptor tyrosine kinase 3	Homo sapiens	66-70	
19411632-5	2009	ITD-Flt3 dramatically increased the number of primary mouse marrow c-kit(+), Sca-1(+), Lin(Neg) cells and colony-forming unit granulocyte-macrophages (CFU-GMs) able to proliferate in the absence of growth factors, whereas Survivin deletion significantly reduced growth factor-independent proliferation and increased apoptosis, which was further accentuated by SU5416.	Semaxinib	360-366	fms related receptor tyrosine kinase 3	Homo sapiens	4-8